Anti-CD19 BiTE blinatumomab induces high complete remission rate and prolongs overall survival in adult patients with relapsed/refractory B-precursor ALL

Topp, M. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H-A and Reichle, A. and Marks, R. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M-E and Einsele, H. and Hoelzer, D. and Bargou, R. (2012) Anti-CD19 BiTE blinatumomab induces high complete remission rate and prolongs overall survival in adult patients with relapsed/refractory B-precursor ALL. ONKOLOGIE, 35 (suppl6). p. 186. ISSN 0378-584X

Full text not available from this repository.

Item Type:	Article
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Petra Gürster
Date Deposited:	25 May 2020 10:49
Last Modified:	25 May 2020 10:49
URI:	https://pred.uni-regensburg.de/id/eprint/17986

Actions (login required)

View Item